Characteristics and Patterns of Retention in Hypertension Care in Primary Care Settings From the Hypertension Treatment in Nigeria Program

Jiancheng Ye, Ikechukwu A Orji, Abigail S Baldridge, Tunde M Ojo, Grace Shedul, Eugenia N Ugwuneji, Nonye B Egenti, Kasarachi Aluka-Omitiran, Rosemary C B Okoli, Helen Eze, Ada Nwankwo, Lisa R Hirschhorn, Aashima Chopra, Boni M Ale, Gabriel L Shedul, Priya Tripathi, Namratha R Kandula, Mark D Huffman, Dike B Ojji, Hypertension Treatment in Nigeria Program Investigators, Regina Asuku, Elizabeth Ngadda, Joel Abu, Alice Osuji, Blessing Akor, Charity Akor, Christine Archibong, Abubakar Haruna, Confidence Joseph-Alo, Emmanuel Odo, Douglas Okoye, Grace Afolabi, Emmanuel Okpetu, Nana Ripiye, Dorothy Ihegazie, Christian Ukeh, Vivian Chukwuma, Nicholas Baamlong, Sani Mohammed, Deborah Joshua, Saleh Ashafa, Hope Omeiza, Mercy Ikechukwu-Orji, Jiancheng Ye, Ikechukwu A Orji, Abigail S Baldridge, Tunde M Ojo, Grace Shedul, Eugenia N Ugwuneji, Nonye B Egenti, Kasarachi Aluka-Omitiran, Rosemary C B Okoli, Helen Eze, Ada Nwankwo, Lisa R Hirschhorn, Aashima Chopra, Boni M Ale, Gabriel L Shedul, Priya Tripathi, Namratha R Kandula, Mark D Huffman, Dike B Ojji, Hypertension Treatment in Nigeria Program Investigators, Regina Asuku, Elizabeth Ngadda, Joel Abu, Alice Osuji, Blessing Akor, Charity Akor, Christine Archibong, Abubakar Haruna, Confidence Joseph-Alo, Emmanuel Odo, Douglas Okoye, Grace Afolabi, Emmanuel Okpetu, Nana Ripiye, Dorothy Ihegazie, Christian Ukeh, Vivian Chukwuma, Nicholas Baamlong, Sani Mohammed, Deborah Joshua, Saleh Ashafa, Hope Omeiza, Mercy Ikechukwu-Orji

Abstract

Background: More than 1.2 billion adults worldwide have hypertension. High retention in clinical care is essential for long-term management of hypertension, but 1-year retention rates are less than 50% in many resource-limited settings.

Objective: To evaluate short-term retention rates and associated factors among patients with hypertension in primary health care centers in the Federal Capital Territory of Nigeria.

Design, setting, and participants: In this cohort study, data were collected by trained study staff from adults aged 18 years or older at 60 public, primary health care centers in Nigeria between January 2020 and July 2021 as part of the Hypertension Treatment in Nigeria (HTN) Program. Patients with hypertension were registered.

Exposures: Follow-up visit for hypertension care within 37 days of the registration visit.

Main outcomes and measures: The main outcome was the 3-month rolling average 37-day retention rate in hypertension care, calculated by dividing the number of patients who had a follow-up visit within 37 days of their first (ie, registration) visit in the program by the total number of registered patients with hypertension during multiple consecutive 3-month periods. Interrupted time series analyses evaluated trends in retention rates before and after the intervention phase of the HTN Program. Mixed-effects, multivariable regression models evaluated associations between patient-, site-, and area council-level factors, hypertension treatment and control status, and 37-day retention rate.

Results: In total, 10 686 patients (68.3% female; mean [SD] age, 48.8 [12.7] years) were included in the analysis. During the study period, the 3-month rolling average 37-day retention rate was 41% (95% CI, 37%-46%), with wide variability among sites. The retention rate was higher among patients who were older (adjusted odds ratio [aOR], 1.01 per year; 95% CI, 1.01-1.02 per year), were female (aOR, 1.11; 95% CI, 1.01-1.23), had a higher body mass index (aOR, 1.01; 95% CI, 1.00-1.02), were in the Kuje vs the Abaji area council (aOR, 2.25; 95% CI, 1.25-4.04), received hypertension treatment at the registration visit (aOR, 1.27; 95% CI, 1.07-1.50), and were registered during the postintervention period (aOR, 1.16; 95% CI, 1.06-1.26).

Conclusions and relevance: The findings suggest that retention in hypertension care is suboptimal in primary health care centers in Nigeria, although large variability among sites was found. Potentially modifiable and nonmodifiable factors associated with retention were identified and may inform multilevel, contextualized implementation strategies to improve retention.

Conflict of interest statement

Conflict of Interest Disclosures: Dr G. Shedul reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study. Dr Ugwuneji reported receiving nonfinancial support from Resolve to Save Lives during the conduct of the study. Dr Nwankwo reported receiving grants from the NIH during the conduct of the study. Dr Hirschhorn reported receiving grants from the National Heart, Lung, and Blood Institute (NHLBI), NIH during the conduct of the study. Dr G.L. Shedul reported receiving grants from the NIH during the conduct of the study. Dr Kandula reported receiving grants from the NHLBI, NIH during the conduct of the study. Dr Huffman reported having patents planned for combination therapy for the treatment of heart failure, patents pending for heart failure polypills, and a secondary appointment at the George Institute for Global Health, whose social enterprise business, George Health Enterprises Pty Ltd and its subsidiary, George Medicines Pty Ltd, have received investment funds to develop blood pressure–lowering drugs. No other disclosures were reported.

Figures

Figure 1.. Three-Month Rolling Average 37-Day Retention…
Figure 1.. Three-Month Rolling Average 37-Day Retention Rate Between the Registration Visit and First Follow-up Visit for Patients With Hypertension in Primary Health Care Centers in the Federal Capital Territory of Nigeria
Inner horizontal lines of the boxes indicate medians; outer horizontal lines of the boxes, interquartile ranges; and whiskers, 95% CIs. The FCT numbers are the study identification numbers for each of the primary health care centers.
Figure 2.. Interrupted Time Series With Level…
Figure 2.. Interrupted Time Series With Level Change Regression Model Adjusted for Seasonality
Monthly point estimates are based on the observed retention rate, determined from the date of the first (ie, registration) clinic visit. Circles indicate the mean 37-day retention rate in each month; whiskers, 95% CIs; solid line, predicted 37-day retention rate trend based on the seasonally adjusted regression model; dotted line, predicted 37-day retention rate trend without intervention; dashed line, deseasonalized trend; and shaded area, implementation phase.

References

    1. Wang H, et al. ; GBD 2016 Mortality Collaborators . Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1084-1150. doi:10.1016/S0140-6736(17)31833-0
    1. Havas S, Roccella EJ, Lenfant C. Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium. Am J Public Health. 2004;94(1):19-22. doi:10.2105/AJPH.94.1.19
    1. World Health Organization . Hypertension. August 25, 2021. Accessed August 25, 2021.
    1. Odili AN, Chori BS, Danladi B, et al. . Prevalence, awareness, treatment and control of hypertension in Nigeria: data from a nationwide survey 2017. Glob Heart. 2020;15(1):47. doi:10.5334/gh.848
    1. Howden-Chapman P, Siri J, Chisholm E, Chapman R, Doll CNH, Capon A. SDG 3: Ensure Healthy Lives and Promote Wellbeing for All at All Ages: A Guide to SDG Interactions: From Science to Implementation. International Council for Science; 2017:81-126.
    1. Akinlua JT, Meakin R, Umar AM, Freemantle N. Current prevalence pattern of hypertension in Nigeria: a systematic review. PLoS One. 2015;10(10):e0140021. doi:10.1371/journal.pone.0140021
    1. World Health Organization . Hearts: technical package for cardiovascular disease management in primary health care. 2021. Accessed January 6, 2021.
    1. Fox AD, Anderson MR, Bartlett G, Valverde J, Starrels JL, Cunningham CO. Health outcomes and retention in care following release from prison for patients of an urban post-incarceration transitions clinic. J Health Care Poor Underserved. 2014;25(3):1139-1152. doi:10.1353/hpu.2014.0139
    1. Baldridge A, Orji A, Omitiran K, et al. . Capacity and site readiness for hypertension control program implementation in the Federal Capital Territory of Nigeria: a cross-sectional study. Health Serv Res. 2020;55(S1):67. doi:10.1111/1475-6773.13421
    1. Vedanthan R, Kamano JH, DeLong AK, et al. . Community health workers improve linkage to hypertension care in western Kenya. J Am Coll Cardiol. 2019;74(15):1897-1906. doi:10.1016/j.jacc.2019.08.003
    1. Vedanthan R, Kamano JH, Naanyu V, et al. . Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial. Trials. 2014;15(1):143. doi:10.1186/1745-6215-15-143
    1. Pastakia SD, Manyara SM, Vedanthan R, et al. . Impact of bridging income generation with group integrated care (BIGPIC) on hypertension and diabetes in rural western Kenya. J Gen Intern Med. 2017;32(5):540-548. doi:10.1007/s11606-016-3918-5
    1. World Health Organization . Improving hypertension control in 3 million people: country experiences of programme development and implementation. 2020. Accessed October 13, 2020.
    1. Federal Ministry of Health. Nigeria national hypertension treatment protocol for primary health care level. Accessed January 6, 2021.
    1. Vandenbroucke JP, von Elm E, Altman DG, et al. ; STROBE Initiative . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297. doi:10.1371/journal.pmed.0040297
    1. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217-226. doi:10.1097/MLR.0b013e3182408812
    1. Ojji DB, Baldridge AS, Orji IA, et al. ; Hypertension Treatment in Nigeria Program Investigators . Characteristics, treatment, and control of hypertension in public primary healthcare centers in Nigeria: baseline results from the Hypertension Treatment in Nigeria Program. J Hypertens. 2022;40(5):888-896. doi:10.1097/HJH.0000000000003089
    1. Baldridge AS, Aluka-Omitiran K, Orji IA, et al. . Hypertension Treatment in Nigeria (HTN) Program: rationale and design for a type 2 hybrid, effectiveness, and implementation interrupted time series trial. Implement Sci Commun. 2022;3(1):84. doi:10.1186/s43058-022-00328-9
    1. Jaffe MG, Young JD. The Kaiser Permanente Northern California story: improving hypertension control from 44% to 90% in 13 years (2000 to 2013). J Clin Hypertens (Greenwich). 2016;18(4):260-261. doi:10.1111/jch.12803
    1. Mugavero MJ, Westfall AO, Zinski A, et al. ; Retention in Care (RIC) Study Group . Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61(5):574-580. doi:10.1097/QAI.0b013e318273762f
    1. Ye J, Zhang R, Bannon JE, et al. . Identifying practice facilitation delays and barriers in primary care quality improvement. J Am Board Fam Med. 2020;33(5):655-664. doi:10.3122/jabfm.2020.05.200058
    1. World Health Organization . Guideline for the pharmacological treatment of hypertension in adults: web annex A: summary of evidence. 2021. Accessed August 24, 2021.
    1. Okoli RCB, Shedul G, Hirschhorn LR, et al. . Stakeholder perspectives to inform adaptation of a hypertension treatment program in primary healthcare centers in the Federal Capital Territory, Nigeria: a qualitative study. Implement Sci Commun. 2021;2(1):97. doi:10.1186/s43058-021-00197-8
    1. Harris PA, Taylor R, Minor BL, et al. ; REDCap Consortium . The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi:10.1016/j.jbi.2019.103208
    1. Spiess A-N, Neumeyer N. An evaluation of R2 as an inadequate measure for nonlinear models in pharmacological and biochemical research: a Monte Carlo approach. BMC Pharmacol. 2010;10(1):6. doi:10.1186/1471-2210-10-6
    1. GBD 2019 Viewpoint Collaborators . Five insights from the global burden of disease study 2019. Lancet. 2020;396(10258):1135-1159. doi:10.1016/S0140-6736(20)31404-5
    1. Kuria N, Reid A, Owiti P, et al. . Compliance with follow-up and adherence to medication in hypertensive patients in an urban informal settlement in Kenya: comparison of three models of care. Trop Med Int Health. 2018;23(7):785-794. doi:10.1111/tmi.13078
    1. Musicha C, Crampin AC, Kayuni N, et al. . Accessing clinical services and retention in care following screening for hypertension and diabetes among Malawian adults: an urban/rural comparison. J Hypertens. 2016;34(11):2172-2179. doi:10.1097/HJH.0000000000001070
    1. Adler AJ, Laar A, Prieto-Merino D, et al. . Can a nurse-led community-based model of hypertension care improve hypertension control in Ghana? results from the ComHIP cohort study. BMJ Open. 2019;9(4):e026799. doi:10.1136/bmjopen-2018-026799
    1. Arora S, Kalishman SG, Thornton KA, et al. . Project ECHO: a telementoring network model for continuing professional development. J Contin Educ Health Prof. 2017;37(4):239-244. doi:10.1097/CEH.0000000000000172
    1. Nelissen HE, Cremers AL, Okwor TJ, et al. . Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria—a mixed methods feasibility study. BMC Health Serv Res. 2018;18(1):934. doi:10.1186/s12913-018-3740-3
    1. Boima V, Ademola AD, Odusola AO, et al. . Factors associated with medication nonadherence among hypertensives in Ghana and Nigeria. Int J Hypertens. 2015;2015:205716. doi:10.1155/2015/205716
    1. Bosworth HB, Olsen MK, Neary A, et al. . Take Control of Your Blood Pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008;70(3):338-347. doi:10.1016/j.pec.2007.11.014
    1. Osetinsky B, Genberg BL, Bloomfield GS, et al. . Hypertension control and retention in care among HIV infected patients: the effects of co-located HIV and chronic non-communicable disease care. J Acquir Immune Defic Syndr. 2019;82(4):399-406. doi:10.1097/QAI.0000000000002154
    1. Bobrow K, Farmer AJ, Springer D, et al. . Mobile phone text messages to support treatment adherence in adults with high blood pressure (SMS-Text Adherence Support [StAR]): a single-blind, randomized trial. Circulation. 2016;133(6):592-600. doi:10.1161/CIRCULATIONAHA.115.017530
    1. Labhardt ND, Balo JR, Ndam M, Manga E, Stoll B. Improved retention rates with low-cost interventions in hypertension and diabetes management in a rural African environment of nurse-led care: a cluster-randomised trial. Trop Med Int Health. 2011;16(10):1276-1284. doi:10.1111/j.1365-3156.2011.02827.x
    1. Magadza C, Radloff SE, Srinivas SC. The effect of an educational intervention on patients’ knowledge about hypertension, beliefs about medicines, and adherence. Res Social Adm Pharm. 2009;5(4):363-375. doi:10.1016/j.sapharm.2009.01.004
    1. Ye J, Sanuade O, Baldridge A, et al. . Strategies and contextual factors to improve retention in care for patients with hypertension in primary care: protocol for a systematic review. PROSPERO identifier: CRD42021291368. Accessed December 15, 2021.

Source: PubMed

3
S'abonner